HAYWARD, Calif., April 17, 2012 /PRNewswire/ -- Solta Medical,
Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics
market, today confirmed its plan to release the Company's financial
results for the first quarter ended March
31, 2012, after market close on Tuesday, May 1, 2012. The Company will also
host a conference call and webcast on Tuesday, May 1, 2012, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial
results and current corporate developments. The dial-in number
for the conference call is 877-941-6010 for domestic participants
and 480-629-9770 for international participants.
To access the live webcast of the call, go to Solta Medical's
website at www.solta.com and click on Investor Relations. An
archived webcast will also be available at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers six aesthetic energy devices to
address a range of issues, including skin resurfacing and
rejuvenation with Fraxel® and Clear + Brilliant™, body contouring
and skin tightening with Liposonix® and Thermage® and acne
reduction with Isolaz® and CLARO™. As the innovator and leader in
fractional laser technology, Fraxel delivers minimally invasive
clinical solutions to resurface aging and sun damaged skin. Clear +
Brilliant is a unique, cost-effective treatment to prevent and
improve the early signs of photoaging utilizing Fraxel technology.
For body contouring, Liposonix is a non-surgical treatment to
reduce waist circumference with advanced high-intensity focused
ultrasound (HIFU) technology to permanently destroy targeted fat
beneath the skin. Thermage is an innovative, non-invasive
radiofrequency procedure for tightening and contouring skin. Isolaz
was the first laser or light based system indicated for the
treatment of inflammatory acne, comedonal acne, pustular acne, and
mild-to-moderate inflammatory acne. CLARO is a personal care acne
system that is the first FDA cleared over-the-counter IPL device
that uses a powerful combination of both heat and light to clear
skin quickly and naturally. More than two million procedures have
been performed with Solta Medical's portfolio of products around
the world. For more information about Solta Medical, call
1-877-782-2286 or log on to www.Solta.com.
© 2012 Solta Medical, Inc. All rights reserved. Thermage,
Fraxel, Isolaz, Clear + Brilliant, CLARO, Liposonix and Solta
Medical are trademarks or registered trademarks of Solta Medical,
Inc. or its subsidiaries.
SOURCE Solta Medical, Inc.